– Dr. Mehta joins Dren Bio from Genentech where he served as Vice President and Head of Business Development, bringing two decades of industry experience spanning drug development, operations and strategic partnering –

FOSTER CITY, Calif.–(BUSINESS WIRE)–October 30, 2023–

Dren Bio, Inc. (“Dren Bio” or the “Company”) a clinical-stage biopharmaceutical company developing antibody therapeutics for cancer, autoimmune and other serious diseases, today announced the expansion of…